Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lasa Supergenerics Ltd has announced a board meeting scheduled for May 29, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting is being held pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015. Additionally, the trading window will remain closed for insiders until 48 hours after the results are declared. This is a standard procedural intimation filing and does not contain any specific financial figures or qualitative disclosures about the company's performance.
This is a routine announcement informing shareholders of an upcoming board meeting to approve audited results. The closure of the trading window indicates that insiders are restricted from trading until results are disclosed, which is standard practice. No immediate stock price impact is expected from this filing alone.